3月6日,现代中药集团(01643)发布公告,预计2024年度净利润为800万元至1200万元,2023年度约4880万元的净利润。
净利润下降的原因为:2024年2月至5月期间,因制剂车间进行修缮工程导致暂时停产及受国家新政策影响以及活跃客户数量下降导致收益减少;拆除制剂车间导致的物业、厂房及设备处置损失。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.